logo
  • Home
  • News
Menu

Pharma company’s stock plunges 70% after bad news from FDA

Home / Stock Analysis / Pharma company’s stock plunges 70% after bad news from FDA
Article feature image

Pharma company’s stock plunges 70% after bad news from FDA

19 Jul Stock Analysis

Shares in Ardelyx Inc.
ARDX,
+2.67%
plummeted more than 70% in after-hours trading Monday, following the biopharmaceutical company’s announcement that the Food and Drug Administration appears unlikely to approve a drug for dialysis patients. Ardelyx…

Click here to view the original article.

Tags:
Global, MarketWatch
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

1585186556238.jpeg
+

With A 28% Price Drop For The Trade Desk, Inc. (NASDAQ:TTD) You’ll Still Get What You Pay For

09 Aug Stock Analysis
1585186668959.jpeg
+

Selling Expensify Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders

09 Aug Stock Analysis

recent post

  • 0198903c-6dff-7c0a-8ea2-edb7bd2d858e.jpeg

    Institutions and Big Banks Dominating Crypto

    Aug 09 2025
  • og-image-news-20240226.png

    Institutional Investors Drive Centralization in Regulated

    Aug 09 2025
  • 019890a2-3ecc-74f1-8975-9f17742106c9.jpeg

    Bo Hines, Leader of the White

    Aug 09 2025
  • 6897b15edd67840477924228_6897b15dba0beecdb7f72c46_lastImage.png

    Trump’s Executive Order on Crypto Banking:

    Aug 09 2025
  • image-15.png

    Embargo Ransomware nets $34.2M in crypto

    Aug 09 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.